Minocycline HCl

Moxifioxacin hydrochlodde is one of the two new fluoroquinolonecarboxylic acid antibiotics introduced in 1999 for the treatment of respiratory tract infections such as community-acquired pneumonia, acute exacerbations of bronchitis or acute sinusitis. Moxifloxacin can be synthesized through a 12 step sequence from the classical 4-quinolone-3-carboxylic acid template. Some advantages of Moxifloxacin over Ciprofloxacin, another of Bayer's launched quinolones, have been shown, i.e. an enhanced activity against Gram-positive bacteria (Streptococcus pneumoniae, Clostndium pneumoniae), a favorable pharmacokinetic profile (good tissue penetration and plasma concentrations above MICs) and a lack of phototoxicity (UVA irradiation). 

Moxifloxacin can be used to treat social acquired pneumonia caused by Staphylococcus aureus, influenza bacilli, pneumococcus, acute attack of chronic bronchitis, acute sinusitis, etc. It belongs to the fourth generation of quinolone antibiotics and is a new generation of broad spectrum antibiotics. It has strong antimicrobial activity against common respiratory pathogens such as Streptococcus pneumoniae, Haemophilus, Morahan catarrhalis and some Staphylococcus aureus, especially Streptococcus pneumoniae. It is clinically used to treat acute sinus adenitis, acute exacerbation of chronic bronchitis) community acquired pneumonia, as well as non-complications of skin and soft tissue 

Moxifloxacin Hydrochloride is a fluoroquinolone antibiotic developed by Bayer Pharmaceuticals (Germany.) It can be used to treat community-acquired pneumonia caused by Staphylococcus aureus, baccilus, pneumococcus, mucositis Moraxella, and Klebsiella pneumoniae, acute chronic bronchitis attacks, and acute sinusitis. For the treatment of adult bacterial lung infections, paranasal sinus, skin, and abdominal cavity. Also used to treat community-acquired pneumonia, chronic bronchitis, urogenital infection, and acute sinusitis.

Anyị nwere ọtụtụ ụlọ ọrụ dị elu nke nwere nkwado miri emi, nke nwere ike inye gị ngwaahịa dị elu na ọnụ ahịa asọmpi. Anyị nwekwara ike inye ego maka nnukwu ịzụrụ ihe. Anyị na-akwado ọtụtụ ụlọ ọrụ na-ebuga ibu ndị ọkachamara, nwere ike ịnapụta ngwaahịa n'enweghị nsogbu na aka gị. Oge nnyefe bụ ihe dịka ụbọchị 3-20 mgbe nkwenye nke ịkwụ ụgwọ gasịrị.

Minocycline Hydrochloride is a semisynthetic tetracycline class,broad-spectrum antibiotics in the tetracycline class of antibiotics,the product of the strongest activity.To gram-positive bacteria including tetracycline resistance of staphylococcus aureus,streptococcus and gram-negative bacteria such as gonorrhea netheril bacteria have a strong role; For chlamydia trachomatis and dissolving urea mycoplasma also has better inhibition.

1. Ị bụ ụlọ ọrụ mmepụta ihe ma ọ bụ ụlọ ọrụ ịzụ ahịa?
Anyị bụ ụlọ ọrụ na-ejikọta ụlọ ọrụ na ịzụ ahịa, na-enye ọrụ nkwụsịtụ.OEM nwere ike ịnakwere.

2. Ị na-enye samples? Ọ bụ n'efu ka ọ bụ mgbakwunye?
Free samples. The sample si ibu ego kwesịrị ịkwụ ụgwọ gị n'akụkụ.

3. Ị nwere asambodo ọ bụla metụtara njikwa mma?
ISO 9001: 2008 asambodo iji hụ na ịdị mma.

4. Kedu ihe m ga-enye ka m nweta nhota okwu?
Pls na-agwa anyị ụdị ngwaahịa nke ị chọrọ, iji ọnụ ọgụgụ, adreesị na ihe ndị a chọrọ. A ga-edepụta nkwupụta maka ntinye aka gị n'oge.

5. Kedu ụdị usoro ịkwụ ụgwọ na-amasị gị? Kedu ụdị usoro anabatara?
Usoro nnyefe anabatara: FOB, CFR, CIF, EXW;
Ego ịkwụ ụgwọ anabatara: USD;
Ụdị ịkwụ ụgwọ anabatara: T/T, Western Union; Paypal, ahia ahia.
Asụsụ Asụsụ: Bekee.